Stanley-Laman Group’s Aceragen Inc ACGN Stock Holding History

Stanley-Laman Group’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,561	Closed	-$1.02M	–	289
2017 Q4	$1.02M	Buy	+3,561	New	+$1.02M	0.22%	126

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Stanley-Laman Group's ACGN Position: Q1 2018 in Review

Stanley-Laman Group sold out of Aceragen Inc (ACGN) in Q1 2018, closing a stake of 3,561 shares — an estimated $1.02M sold.

Stanley-Laman Group first reported a position in ACGN in Q4 2017 and held it in 1 quarter. The position peaked at $1.02M in Q4 2017. 107 funds tracked by Wall St. Rank hold ACGN as of Q1 2018.

Stanley-Laman Group reported no remaining Aceragen Inc position as of Q1 2018 after selling out during the quarter.
Stanley-Laman Group sold 3,561 Aceragen Inc shares in Q1 2018, an estimated $1.02M.
Stanley-Laman Group first reported a position in Aceragen Inc in Q4 2017 and held it in 1 quarter.
Stanley-Laman Group's Aceragen Inc position peaked at $1.02M in Q4 2017.
107 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2018.

Based on Stanley-Laman Group's 13F filing for Q1 2018, filed 1 May 2018.